novo nordisk glp-1 receptor agonist promotes new to fight diabetes, obesity < Pharma < Article ANSE1024_0051_table_a.jpg

McDonalds, the worlds largest fast-food chain, claims that it has not yet seen an impact on their business due to GLP-1 drugs, but acknowledges that future impact is uncertain

Furthermore, its fat-burning effects make it an exciting potential treatment option for diseases that involve excess fat buildup on internal organs, such as type 2 diabetes and metabolic-associated steatotic liver disease (MASLD)

GLP-1 DrugsFebruary 6, 2026 The next wave of GLP-1 drugs are comingand theyre stronger than Wegovy and Zepbound The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments

GLP1 receptors exist in areas of the brain involved in reward and addictive behaviors, which may explain why many patients naturally drink less during treatment

Although the data are preliminary and mixed, this area shows promising potential (Sola-Leyva et al., 2024)